Cognitive-behavioral management of motion sickness.
This monograph is intended to provide health professionals with information on a cognitive-behavioral technique which was developed to teach individuals who are prone to motion sickness to better cope with motion environments. It includes an overview of motion sickness, describing the signs and symptoms, etiology and incidence of this malady. Prevention and treatment are then reviewed, including both pharmacological and non-pharmacological therapies. The historical background on the cognitive-behavioral technique is then discussed. This is followed by a review of supporting experimental work, and an account of how such counselling should be carried out. Finally, a number of current military desensitization programs are compared and contrasted with cognitive-behavioral therapy.
Dobie
T G
TG
Motion Sciences Department, Naval Biodynamics Laboratory, New Orleans, LA 70189-0407.
May
J G
JG
D001676:Biofeedback, Psychology; D002936:Cinnarizine / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003887:Desensitization, Psychologic; D003913:Dextroamphetamine / Q000627:therapeutic use; D018475:Head-Down Tilt; D006801:Humans; D011398:Promethazine / Q000627:therapeutic use; D012601:Scopolamine / Q000627:therapeutic use; D018489:Space Motion Sickness / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D018667:Tilt-Table Test
D002936:Cinnarizine; D012601:Scopolamine; D011398:Promethazine; D003913:Dextroamphetamine